Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media

Infection and Immunity

Volumn 78, Issue 5, 2010, Pages 1841-1849

  Senkovich, Olga ^a   Ceaser, Shantelle ^a   McGee, David J ^a   Testerman, Traci L ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; LACTOFERRIN; TRANSFERRIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; HELICOBACTER PYLORI; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEPLETION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CATTLE; CULTURE MEDIA; HELICOBACTER PYLORI; HEMOGLOBINS; HUMANS; IRON; LACTOFERRIN; TRANSFERRIN;

EID: 77951229636     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01258-09     Document Type: Article

References (41)

1. Andrews, S. C., A. K. Robinson, and F. Rodriguez-Quinones. 2003. Bacterial iron homeostasis. FEMS Microbiol. Rev. 27:215-237.
2. Ascencio, F., A. Ljungh, and T. Wadstrom. 1992. Lactoferrin binding properties of Vibrio cholerae. Microbios 70:103-117.
3. Aspholm, M., F. O. Olfat, J. Norden, B. Sonden, C. Lundberg, R. Sjostrom, S. Altraja, S. Odenbreit, R. Haas, T. Wadstrom, L. Engstrand, C. Semino-Mora, H. Liu, A. Dubois, S. Teneberg, A. Arnqvist, and T. Boren. 2006. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2:e110.
4. Bahrami, F., A. Elkins, and D. F. Niven. 2003. Iron acquisition by Actinobacillus suis: identification and characterization of transferrin receptor proteins and encoding genes. Vet. Microbiol. 94:79-92.
5. Boulton, I. C., A. R. Gorringe, N. Allison, A. Robinson, B. Gorinsky, C. L. Joannou, and R. W. Evans. 1998. Transferrin-binding protein B isolated from Neisseria meningitidis discriminates between apo and diferric human transferrin. Biochem. J. 334:269-273.
6. Cabantchik, Z. I., O. Kakhlon, S. Epsztejn, G. Zanninelli, and W. Breuer. 2002. Intracellular and extracellular labile iron pools. Adv. Exp. Med. Biol. 509:55-75.
7. Carpenter, B. M., T. K. McDaniel, J. M. Whitmire, H. Gancz, S. Guidotti, S. Censini, and D. S. Merrell. 2007. Expanding the Helicobacter pylori genetic toolbox: modification of an endogenous plasmid for use as a transcriptional reporter and complementation vector. Appl. Environ. Microbiol. 73:7506-7514.
8. Cornelissen, C. N., and P. F. Sparling. 1994. Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol. Microbiol. 14:843-850.
9. Dalmastri, C., P. Valenti, P. Visca, P. Vittorioso, and N. Orsi. 1988. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. Microbiologica 11:225-230.
10. Davis, B. A., and J. B. Porter. 2002. Results of long term iron chelation treatment with deferoxamine. Adv. Exp. Med. Biol. 509:91-125.
11. de Bortoli, N., G. Leonardi, E. Ciancia, A. Merlo, M. Bellini, F. Costa, M. G. Mumolo, A. Ricchiuti, F. Cristiani, S. Santi, M. Rossi, and S. Marchi. 2007. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am. J. Gastroenterol. 102:951-956.
12. Dhaenens, L., F. Szczebara, S. Van Nieuwenhuyse, and M. O. Husson. 1999. Comparison of iron uptake in different Helicobacter species. Res. Microbiol. 150:475-481.
13. Dionysius, D. A., and J. M. Milne. 1997. Antibacterial peptides of bovine lactoferrin: purification and characterization. J. Dairy Sci. 80:667-674. (Pubitemid 127446978)
14. Ellison, R. T., III. 1994. The effects of lactoferrin on gram-negative bacteria. Adv. Exp. Med. Biol. 357:71-90.
15. Genco, C. A., and D. W. Dixon. 2001. Emerging strategies in microbial haem capture. Mol. Microbiol. 39:1-11.
16. Gonzalez-Lopez, M. A., and J. J. Olivares-Trejo. 2009. The gene frpB2 of Helicobacter pylori encodes an hemoglobin-binding protein involved in iron acquisition. Biometals 22:889-894.
17. Herrington, D. A., and P. F. Sparling. 1985. Haemophilus influenzae can use human transferrin as a sole source for required iron. Infect. Immun. 48:248-251.
18. Husson, M. O., D. Legrand, G. Spik, and H. Leclerc. 1993. Iron acquisition by Helicobacter pylori: importance of human lactoferrin. Infect. Immun. 61:2694-2697.
19. Huynh, H. Q., M. A. Campbell, R. T. Couper, C. D. Tran, A. Lawrence, and R. N. Butler. 2009. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice. Lett. Appl. Microbiol. 48:517-522.
20. Keenan, J. I., R. A. Peterson, R. Fraser, C. M. Frampton, T. A. Walmsley, R. A. Allardyce, and J. A. Roake. 2004. The effect of Helicobacter pylori infection and dietary iron deficiency on host iron homeostasis: a study in mice. Helicobacter 9:643-650.
21. Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386-1397.
22. Loh, J. T., M. H. Forsyth, and T. L. Cover. 2004. Growth phase regulation of flaA expression in Helicobacter pylori is luxS dependent. Infect. Immun. 72:5506-5510.
23. Martino, M. C., R. A. Stabler, Z. W. Zhang, M. J. Farthing, B. W. Wren, and N. Dorrell. 2001. Helicobacter pylori pore-forming cytolysin orthologue TlyA possesses in vitro hemolytic activity and has a role in colonization of the gastric mucosa. Infect. Immun. 69:1697-1703.
24. Mazurier, J., J. M. Lhoste, J. Montreuil, and G. Spik. 1983. Comparative study of the iron-binding properties of human transferrins. II. Electron paramagnetic resonance of mixed metal complexes of human lactotransferrin. Biochim. Biophys. Acta 745:44-49.
25. McGee, D. J., C. Coker, T. L. Testerman, J. M. Harro, S. V. Gibson, and H. L. Mobley. 2002. The Helicobacter pylori flbA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J. Med. Microbiol. 51:958-970.
26. Mobley, H. L., M. J. Cortesia, L. E. Rosenthal, and B. D. Jones. 1988. Characterization of urease from Campylobacter pylori. J. Clin. Microbiol. 26:831-836.
27. Muhsen, K., and D. Cohen. 2008. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 13:323-340.
28. Nakao, K., I. Imoto, N. Ikemura, T. Shibata, S. Takaji, Y. Taguchi, M. Misaki, K. Yamauchi, and N. Yamazaki. 1997. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. Am. J. Gastroenterol. 92:1005-1011.
29. Ogunnariwo, J. A., and A. B. Schryvers. 1990. Iron acquisition in Pasteurella haemolytica: expression and identification of a bovine-specific transferrin receptor. Infect. Immun. 58:2091-2097.
30. Otto, B. R., A. M. Verweij-van Vught, and D. M. MacLaren. 1992. Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit. Rev. Microbiol. 18:217-233.
31. Retzer, M. D., R. Yu, Y. Zhang, G. C. Gonzalez, and A. B. Schryvers. 1998. Discrimination between apo and iron-loaded forms of transferring by transferrin binding protein B and its N-terminal subfragment. Microb. Pathog. 25:175-180.
32. Stojiljkovic, I., V. Kumar, and N. Srinivasan. 1999. Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. Mol. Microbiol. 31:429-442.
33. Testerman, T. L., P. B. Conn, H. L. Mobley, and D. J. McGee. 2006. Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J. Clin. Microbiol. 44:1650-1658.
34. Tursi, A., W. Elisei, G. Brandimarte, G. M. Giorgetti, M. E. Modeo, and F. Aiello. 2007. Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med. Sci. Monit. 13:CR187-CR190. (Pubitemid 46557753)
35. Velayudhan, J., N. J. Hughes, A. A. McColm, J. Bagshaw, C. L. Clayton, S. C. Andrews, and D. J. Kelly. 2000. Iron acquisition and virulence in Helicobacter pylori: a major role for FeoB, a high-affinity ferrous iron transporter. Mol. Microbiol. 37:274-286.
36. Williams, J. C., K. A. McInnis, and T. L. Testerman. 2008. Adherence of Helicobacter pylori to abiotic surfaces is influenced by serum. Appl. Environ. Microbiol. 74:1255-1258.
37. Worst, D. J., M. M. Gerrits, C. M. Vandenbroucke-Grauls, and J. G. Kusters. 1998. Helicobacter pylori ribBA-mediated riboflavin production is involved in iron acquisition. J. Bacteriol. 180:1473-1479.
38. Worst, D. J., B. R. Otto, and J. de Graaff. 1995. Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infect. Immun. 63:4161-4165.
39. Yokota, S. I., M. Konno, E. Mino, K. Sato, M. Takahashi, and N. Fujii. 2008. Enhanced Fe ion-uptake activity in Helicobacter pylori strains isolated from patients with iron-deficiency anemia. Clin. Infect. Dis. 46:e31-33.
40. Zullo, A., V. De Francesco, G. Scaccianoce, C. Hassan, A. Panarese, D. Piglionica, C. Panella, S. Morini, and E. Ierardi. 2005. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study. Dig. Liver Dis. 37:496-500.
41. Zullo, A., V. De Francesco, G. Scaccianoce, G. Manes, C. Efrati, C. Hassan, G. Maconi, D. Piglionica, C. Cannaviello, C. Panella, S. Morini, and E. Ierardi. 2007. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. Dig. Liver Dis. 39:806-810.